APA (7th ed.) Citation

Long, S. A., Rieck, M., Sanda, S., Bollyky, J. B., Samuels, P. L., Goland, R., . . . Greenbaum, C. J. (2012). Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs yet Transiently Impairs β-Cell Function. Diabetes (New York, N.Y.), 61(9), 2340-2348. https://doi.org/10.2337/db12-0049

Chicago Style (17th ed.) Citation

Long, S. Alice, et al. "Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs yet Transiently Impairs β-Cell Function." Diabetes (New York, N.Y.) 61, no. 9 (2012): 2340-2348. https://doi.org/10.2337/db12-0049.

MLA (9th ed.) Citation

Long, S. Alice, et al. "Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs yet Transiently Impairs β-Cell Function." Diabetes (New York, N.Y.), vol. 61, no. 9, 2012, pp. 2340-2348, https://doi.org/10.2337/db12-0049.